Levin Capital Strategies’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Hold |
36,176
| – | – | 0.07% | 100 |
|
|
2025
Q1 | $698K | Hold |
36,176
| – | – | 0.07% | 95 |
|
|
2024
Q4 | $646K | Hold |
36,176
| – | – | 0.06% | 106 |
|
|
2024
Q3 | $792K | Sell |
36,176
-3,000
| -8% | -$65.7K | 0.08% | 97 |
|
|
2024
Q2 | $306K | Hold |
39,176
| – | – | 0.03% | 146 |
|
|
2024
Q1 | $162K | Hold |
39,176
| – | – | 0.02% | 189 |
|
|
2023
Q4 | $102K | Hold |
39,176
| – | – | 0.01% | 194 |
|
|
2023
Q3 | $73.3K | Hold |
39,176
| – | – | 0.01% | 215 |
|
|
2023
Q2 | $98.3K | Hold |
39,176
| – | – | 0.01% | 228 |
|
|
2023
Q1 | $68.6K | Hold |
39,176
| – | – | 0.01% | 210 |
|
|
2022
Q4 | $166K | Hold |
39,176
| – | – | 0.02% | 185 |
|
|
2022
Q3 | $47K | Hold |
39,176
| – | – | 0.01% | 205 |
|
|
2022
Q2 | $39K | Sell |
39,176
-5,000
| -11% | -$4.98K | ﹤0.01% | 218 |
|
|
2022
Q1 | $108K | Hold |
44,176
| – | – | 0.01% | 236 |
|
|
2021
Q4 | $119K | Buy |
44,176
+414
| +0.9% | +$1.12K | 0.01% | 290 |
|
|
2021
Q3 | $219K | Buy |
43,762
+5,000
| +13% | +$25K | 0.02% | 243 |
|
|
2021
Q2 | $289K | Buy |
38,762
+5,262
| +16% | +$39.2K | 0.03% | 225 |
|
|
2021
Q1 | $197K | Buy |
+33,500
| New | +$197K | 0.02% | 250 |
|